Dyadic International Inc.

2.64-0.0400-1.49%Vol 61.87K1Y Perf -49.24%
Aug 11th, 2022 15:59 DELAYED
BID1.97 ASK3.19
Open2.75 Previous Close2.68
Pre-Market- After-Market-
 - -  - -%
Target Price
6.00 
Analyst Rating
Moderate Buy 2.00
Potential %
127.27 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
17.45 
Earnings Rating
Market Cap74.62M 
Earnings Date
10th Aug 2022
Alpha0.02 Standard Deviation0.17
Beta0.26 

Today's Price Range

2.552.97

52W Range

1.746.89

5 Year PE Ratio Range

-19.70-18.10

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-6.38%
1 Month
-19.27%
3 Months
26.92%
6 Months
-31.25%
1 Year
-49.24%
3 Years
-53.44%
5 Years
95.56%
10 Years
95.56%

TickerPriceChg.Chg.%
DYAI2.64-0.0400-1.49
AAPL168.49-0.7500-0.44
GOOG119.82-0.8300-0.69
MSFT287.02-2.1400-0.74
XOM93.192.62002.89
WFC45.250.92002.08
JNJ167.14-3.5300-2.07
FB196.640.99000.51
GE78.901.76002.28
JPM120.141.75001.48
 
ProfitabilityValueIndustryS&P 500US Markets
24.40
-543.80
-543.80
-645.20
-
RevenueValueIndustryS&P 500US Markets
1.65M
0.06
15.25
28.82
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.09-0.12-33.33
Q01 2022-0.09-0.090.00
Q04 2021-0.04-0.15-275.00
Q03 2021-0.10-0.0640.00
Q02 2021-0.09-0.14-55.56
Q03 2020-0.08-0.09-12.50
Q02 2020-0.05-0.10-100.00
Q01 2020-0.02-0.08-300.00
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-0.09
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume61.87K
Shares Outstanding28.26K
Shares Float19.91M
Trades Count291
Dollar Volume167.84K
Avg. Volume41.22K
Avg. Weekly Volume48.28K
Avg. Monthly Volume38.01K
Avg. Quarterly Volume37.37K

Dyadic International Inc. (NASDAQ: DYAI) stock closed at 2.64 per share at the end of the most recent trading day (a -1.49% change compared to the prior day closing price) with a volume of 61.87K shares and market capitalization of 74.62M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 7 people. Dyadic International Inc. CEO is Mark A. Emalfarb.

The one-year performance of Dyadic International Inc. stock is -49.24%, while year-to-date (YTD) performance is -41.59%. DYAI stock has a five-year performance of 95.56%. Its 52-week range is between 1.7419 and 6.89, which gives DYAI stock a 52-week price range ratio of 17.45%

Dyadic International Inc. currently has a PE ratio of -7.10, a price-to-book (PB) ratio of 5.41, a price-to-sale (PS) ratio of 48.51, a price to cashflow ratio of 52.10, a PEG ratio of 2.32, a ROA of -52.41%, a ROC of -58.44% and a ROE of -58.30%. The company’s profit margin is -%, its EBITDA margin is -543.80%, and its revenue ttm is $1.65 Million , which makes it $0.06 revenue per share.

Of the last four earnings reports from Dyadic International Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.09 for the next earnings report. Dyadic International Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Dyadic International Inc. is Moderate Buy (2), with a target price of $6, which is +127.27% compared to the current price. The earnings rating for Dyadic International Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Dyadic International Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Dyadic International Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 14.61, ATR14 : 0.23, CCI20 : -95.04, Chaikin Money Flow : -0.42, MACD : -0.08, Money Flow Index : 51.60, ROC : -6.38, RSI : 35.61, STOCH (14,3) : 14.06, STOCH RSI : 0.57, UO : 25.41, Williams %R : -85.94), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Dyadic International Inc. in the last 12-months were: Mark A. Emalfarb (Option Excercise at a value of $244 500), Mark A. Emalfarb (Sold 90 902 shares of value $379 503 ), Ronen Tchelet (Option Excercise at a value of $14 041), Ronen Tchelet (Sold 8 943 shares of value $31 202 ), Seth J. Herbst (Option Excercise at a value of $30 250)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (50.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Strong Buy
1.00
Strong Buy
1.00

Dyadic International Inc.

Dyadic International Inc is a biotechnology company engaged in the discovery, development, manufacturing and selling of enzymes and other proteins for the bioenergy, biochemical, industrial enzyme and biopharmaceutical industries.

CEO: Mark A. Emalfarb

Telephone: +1 561 743-8333

Address: 140 Intracoastal Pointe Drive, Jupiter 33477, FL, US

Number of employees: 7

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

52%48%

Bearish Bullish

55%45%

TipRanks News for DYAI

Fri, 13 May 2022 10:35 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: CTI BioPharma (CTIC), Dyadic International (DYAI) and Assembly Biosciences (ASMB)

- TipRanks. All rights reserved.

Mon, 02 May 2022 09:04 GMT Analysts Offer Insights on Healthcare Companies: and Dyadic International (DYAI)

- TipRanks. All rights reserved.

Tue, 11 Jan 2022 11:17 GMT Dyadic International (DYAI) Receives a Buy from H.C. Wainwright

- TipRanks. All rights reserved.

Fri, 07 Jan 2022 09:11 GMT Dyadic International (DYAI) Gets a Buy Rating from Dawson James

- TipRanks. All rights reserved.

News

Stocktwits